Impact of co-occurring genetic events on RAS signaling diversification in NF1-mutant lung adenocarcinoma (LUAC)

被引：0
|
作者：
Skoulidis, Ferdinandos [1 ]
Tong, Pan [1 ]
Wang, Jing [1 ]
Heymach, John V. [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2150
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2150
引用
收藏
页数：2
相关论文
共 15 条
  • [1] IMPACT OF CO-OCCURRING GENETIC EVENTS ON THE SIGNALING LANDSCAPE OF KRAS-MUTANT LUNG ADENOCARCINOMA.
    Skoulidis, Ferdinandos
    Diao, Lixia
    Fan, Youhong
    Minna, John D.
    Weinstein, John N.
    Heymach, John V.
    Wang, Jing
    Byers, Lauren A.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S348 - S348
  • [2] Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma (LUAC) with distinct biology and therapeutic vulnerabilities
    Skoulidis, Ferdinandos
    Byers, Lauren
    Diao, Lixia
    Papadimitrakopoulou, Vassiliki
    Tong, Pan
    Izzo, Julie
    Behrens, Carmen
    Kadara, Humam
    Parra, Edwin R.
    Rodriguez-Canales, Jaime
    Zhang, Jianjun
    Giri, Uma
    Gudikote, Jayanthi
    Cortez, Maria Angelica
    Yang, Chao
    Fan, You Hong
    Peyton, Michael
    Girard, Luc
    Coombes, Kevin R.
    Toniatti, Carlo
    Heffernan, Timothy P.
    Choi, Murim
    Frampton, Garrett M.
    Miller, Vincent
    Weinstein, John N.
    Herbst, Roy S.
    Wong, Kwok-Kin
    Zhang, Jianhua
    Sharma, Padmanee
    Mills, Gordon M.
    Hong, Waun Ki
    Minna, John D.
    Allison, James P.
    Futreal, Andrew
    Wang, Jing
    Wistuba, Ignacio
    Heymach, John V.
    CANCER RESEARCH, 2015, 75
  • [3] Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
    Collin M Blakely
    Thomas B K Watkins
    Wei Wu
    Beatrice Gini
    Jacob J Chabon
    Caroline E McCoach
    Nicholas McGranahan
    Gareth A Wilson
    Nicolai J Birkbak
    Victor R Olivas
    Julia Rotow
    Ashley Maynard
    Victoria Wang
    Matthew A Gubens
    Kimberly C Banks
    Richard B Lanman
    Aleah F Caulin
    John St John
    Anibal R Cordero
    Petros Giannikopoulos
    Andrew D Simmons
    Philip C Mack
    David R Gandara
    Hatim Husain
    Robert C Doebele
    Jonathan W Riess
    Maximilian Diehn
    Charles Swanton
    Trever G Bivona
    Nature Genetics, 2017, 49 : 1693 - 1704
  • [4] Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
    Blakely, Collin M.
    Watkins, Thomas B. K.
    Wu, Wei
    Gini, Beatrice
    Chabon, Jacob J.
    McCoach, Caroline E.
    McGranahan, Nicholas
    Wilson, Gareth A.
    Birkbak, Nicolai J.
    Olivas, Victor R.
    Rotow, Julia
    Maynard, Ashley
    Wang, Victoria
    Gubens, Matthew A.
    Banks, Kimberly C.
    Lanman, Richard B.
    Caulin, Aleah F.
    St John, John
    Cordero, Anibal R.
    Giannikopoulos, Petros
    Simmons, Andrew D.
    Mack, Philip C.
    Gandara, David R.
    Husain, Hatim
    Doebele, Robert C.
    Riess, Jonathan W.
    Diehn, Maximilian
    Swanton, Charles
    Bivona, Trever G.
    NATURE GENETICS, 2017, 49 (12) : 1693 - +
  • [5] Co-Occurring LKB1 Deficiency Determinates the Susceptibility to ERK-Targeted Therapy in RAS-Mutant Lung Cancer
    Yang, Haitang
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (04) : E58 - E59
  • [6] NF1, MET, and RIT1 mutations are RAS-pathway driver events in lung adenocarcinoma
    Berger, Alice H.
    Brooks, Angela N.
    Imielinski, Marcin
    Cherniack, Andrew
    Duke, Fujiko
    Kaplan, Nathan
    Wala, Jeremiah
    Meyerson, Matthew
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [7] Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
    Skoulidis, Ferdinandos
    Byers, Lauren A.
    Diao, Lixia
    Papadimitrakopoulou, Vassiliki A.
    Tong, Pan
    Izzo, Julie
    Behrens, Carmen
    Kadara, Humam
    Parra, Edwin R.
    Canales, Jaime Rodriguez
    Zhang, Jianjun
    Giri, Uma
    Gudikote, Jayanthi
    Cortez, Maria A.
    Yang, Chao
    Fan, Youhong
    Peyton, Michael
    Girard, Luc
    Coombes, Kevin R.
    Toniatti, Carlo
    Heffernan, Timothy P.
    Choi, Murim
    Frampton, Garrett M.
    Miller, Vincent
    Weinstein, John N.
    Herbst, Roy S.
    Wong, Kwok-Kin
    Zhang, Jianhua
    Sharma, Padmanee
    Mills, Gordon B.
    Hong, Waun K.
    Minna, John D.
    Allison, James P.
    Futreal, Andrew
    Wang, Jing
    Wistuba, Ignacio I.
    Heymach, John V.
    CANCER DISCOVERY, 2015, 5 (08) : 860 - 877
  • [8] Multifocal primary neuroblastoma tumor heterogeneity in siblings with co-occurring PHOX2B and NF1 genetic aberrations
    Rybinski, Brad
    Wolinsky, Tamar
    Brohl, Andrew
    Moerdler, Scott
    Reed, Damon R.
    Ewart, Michelle
    Weiser, Daniel
    GENES CHROMOSOMES & CANCER, 2020, 59 (02): : 119 - 124
  • [9] A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population
    Heredia, David
    Mas, Luis
    Cardona, Andres F.
    Oyervides, Victor
    Guerrero, Rodrigo Motta
    Galvez-Nino, Marco
    Lara-Mejia, Luis
    Aliaga-Macha, Carlos
    Carracedo, Carlos
    Varela-Santoyo, Edgar
    Ramos-Ramirez, Maritza
    Davila-Dupont, David
    Martinez, Juan
    Cruz-Rico, Graciela
    Remon, Jordi
    Arrieta, Oscar
    LUNG CANCER, 2022, 174 : 133 - 140
  • [10] ROS1 resistance mutations and co-occurring genetic alterations to the ROS1 protein-tyrosine kinase inhibitors (crizotinib) in lung cancer
    Weng, Y.
    Cai, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S989 - S989
12